What is the address of Drs. Verhaegen - Thaens?

The registered office of Drs. Verhaegen - Thaens is located at Groenstraat(S) 109, 3270 Scherpenheuvel-Zichem.

Is Drs. Verhaegen - Thaens still active?

Yes. According to the CBE (30 September 2026) Drs. Verhaegen - Thaens is active, legal situation “Normale toestand”, started on 28 May 2018.

Is Drs. Verhaegen - Thaens registered on Peppol?

Yes, Drs. Verhaegen - Thaens is registered on the Peppol network with ID 0208:0696824343.

What is the enterprise number of Drs. Verhaegen - Thaens?

The enterprise number of Drs. Verhaegen - Thaens is BE0696824343.

When was Drs. Verhaegen - Thaens founded?

Drs. Verhaegen - Thaens was founded on 28 May 2018.

Who are the directors of Drs. Verhaegen - Thaens?

According to the 2025 annual accounts, the directors of Drs. Verhaegen - Thaens are: Stijn Verhaegen, Anke Thaens.

Is Drs. Verhaegen - Thaens a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 May 2018; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 2 establishments in the CBE.

How much profit did Drs. Verhaegen - Thaens make in 2025?

Drs. Verhaegen - Thaens posted a profit after taxes of € 86,485 in financial year 2025.

What is the revenue of Drs. Verhaegen - Thaens?

As a small company, Drs. Verhaegen - Thaens is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 117,054.

Drs. Verhaegen - Thaens (Private Limited) - BE0696824343

Dossier Drs. Verhaegen - Thaens, printed on 30 September 2026 from databakkes.be/en/0696824343/drs-verhaegen-thaens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Drs. Verhaegen - Thaens from Scherpenheuvel-Zichem, company number BE0696824343, closed financial year 2025 with a result of € 86,485 after tax. For that financial year Drs. Verhaegen - Thaens recorded a gross margin of € 117,054 and equity of € 18,600. Compared with financial year 2024, the result moved from € 110,456 to € 86,485. The company is profitable. The buffer shrank hard: equity is 88 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.

What it is worth Shrank hard

€ 18,600

▼ 88% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 86,485

▼ 22% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 189,669

▲ 93% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 226,690 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,846

▼ 4% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 21,031

▲ € 19,038 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 222,011 Gross margin 2022: € 222,011 First fiscal year in the series	€ 180,401 Gross margin 2023: € 180,401 ▼ 19% vs 2022 (€ 222,011) Unfavourable step	€ 149,998 Gross margin 2024: € 149,998 ▼ 17% vs 2023 (€ 180,401) Unfavourable step	€ 117,054 Gross margin 2025: € 117,054 ▼ 22% vs 2024 (€ 149,998) Unfavourable step	▼ 22%
Profit after taxes	€ 168,841 Profit after taxes 2022: € 168,841 First fiscal year in the series	€ 139,939 Profit after taxes 2023: € 139,939 ▼ 17% vs 2022 (€ 168,841) Unfavourable step	€ 110,456 Profit after taxes 2024: € 110,456 ▼ 21% vs 2023 (€ 139,939) Unfavourable step	€ 86,485 Profit after taxes 2025: € 86,485 ▼ 22% vs 2024 (€ 110,456) Unfavourable step	▼ 22%
Equity	€ 223,348 Equity 2022: € 223,348 First fiscal year in the series	€ 48,348 Equity 2023: € 48,348 ▼ 78% vs 2022 (€ 223,348) Unfavourable step	€ 158,805 Equity 2024: € 158,805 ▲ 228% vs 2023 (€ 48,348) Favourable step	€ 18,600 Equity 2025: € 18,600 ▼ 88% vs 2024 (€ 158,805) Unfavourable step	▼ 88%
Total debts	€ 128,327 Total debts 2022: € 128,327 First fiscal year in the series	€ 357,255 Total debts 2023: € 357,255 ▲ 178% vs 2022 (€ 128,327) Unfavourable step	€ 5,989 Total debts 2024: € 5,989 ▼ 98% vs 2023 (€ 357,255) Favourable step	€ 242,066 Total debts 2025: € 242,066 ▲ € 236,077 vs 2024 (€ 5,989) Unfavourable step	▲ € 236,077
Cash	€ 104,858 Cash 2022: € 104,858 First fiscal year in the series	€ 78,648 Cash 2023: € 78,648 ▼ 25% vs 2022 (€ 104,858) Unfavourable step	€ 98,454 Cash 2024: € 98,454 ▲ 25% vs 2023 (€ 78,648) Favourable step	€ 189,669 Cash 2025: € 189,669 ▲ 93% vs 2024 (€ 98,454) Favourable step	▲ 93%
Retained profit	€ 204,748 Retained profit 2022: € 204,748 First fiscal year in the series	€ 29,748 Retained profit 2023: € 29,748 ▼ 85% vs 2022 (€ 204,748) Unfavourable step	€ 140,205 Retained profit 2024: € 140,205 ▲ € 110,456 vs 2023 (€ 29,748) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 140,205) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 314,939 Dividend 2023: € 314,939 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 314,939) Unchanged	€ 226,690 Dividend 2025: € 226,690 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 20,915 Bank debt 2023: € 20,915 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 20,915) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 351,676 Balance sheet total 2022: € 351,676 First fiscal year in the series	€ 405,604 Balance sheet total 2023: € 405,604 ▲ 15% vs 2022 (€ 351,676) Unchanged	€ 164,794 Balance sheet total 2024: € 164,794 ▼ 59% vs 2023 (€ 405,604) Unchanged	€ 260,666 Balance sheet total 2025: € 260,666 ▲ 58% vs 2024 (€ 164,794) Unchanged	▲ 58%

Key figures of Drs. Verhaegen - Thaens, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Drs. Verhaegen - Thaens?

What happened at Drs. Verhaegen - Thaens in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 10, 2026 New annual accounts for financial year 2025: profit of € 86,485 (▼ 22% vs 2024). Source: NBB ↗
May 28, 2018 New establishment in Scherpenheuvel-Zichem. KBO
May 28, 2018 New establishment in Heusden-Zolder. KBO
2018 Stijn Verhaegen became a director. NBB
2018 Anke Thaens became a director. NBB
May 28, 2018 Start of the company according to the CBE. KBO

In short

From € 168,841 profit in 2022 to € 86,485 profit in 2025.

Paid € 151,377 in corporate taxes since 2022.

Best year ever: 2022, with € 168,841 profit.

Paid out € 541,629 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Drs. Verhaegen - Thaens? We notify you, reason included.

Follow Drs. Verhaegen - Thaens

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Stijn Verhaegen Anke Thaens

Drs. Verhaegen - Thaens

Behind Drs. Verhaegen - Thaens are Stijn Verhaegen and Anke Thaens.

See the full network in the app

Directors

According to the 2025 annual accounts

Stijn Verhaegen

Director

since 2018

Anke Thaens

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Groenstraat(S) 109

3270 Scherpenheuvel-Zichem

2.276.126.378

Pater R. Van De Wouwerstraat 15

3271 Scherpenheuvel-Zichem

Active since 28 May 2018

2.276.126.477

Pastoor Paquaylaan 129

3550 Heusden-Zolder